Questions Answered
Reference library covering deals, PBM negotiations, drug pricing policy, and the structural mechanics behind pharmaceutical markets.
General
- What does RxInsider cover?
- How does RxInsider source its deal intelligence?
- Who is RxInsider written for?
- What makes RxInsider different from other pharma publications?
- How is RxInsider different from RxNews?
- Does RxInsider accept sponsored content or advertiser influence?
- What is the Deal Tracker?
- How often is the Deal Tracker updated?
- How often is content published?
- Who is the intended audience for RxInsider?
- Does RxInsider accept sponsored content?
- what is the pharma deal
- what is a pharmaceutical distributor
- what is a licensing agreement in pharma
- what is a licensing agreement in business
- who are the largest pharma companies
- who are the big pharma companies
- who are the top pharma companies
- who are the largest drug companies
- what are the largest pharma companies by market cap
- who are the top pharmaceutical companies
- who are the major pharmaceutical companies
- who are the big pharmaceutical companies
- what are the largest pharmaceutical companies by revenue
- what are the top pharma companies in india
- who are the biggest pharmaceutical companies in australia
- what is the most prescribed drug in america
- what is the most used drug in america
- what is the most popular drug in america
- what is the most prescribed medicine in america
- what is the most commonly prescribed drug in america
- what is the most commonly used drug in america
- what is the most used illicit drug in america
- what is the most common prescription drug in america
- what is the most popular prescription drug in america
- who is the new ceo of walmart
- what is the most prescribed medication in america
- what is the most used drug in north america
- what are the largest pharmaceutical companies in america
- who is the new ceo of novo nordisk
Cost
Data & Methods
Deals & M&A
- What is the difference between M&A and licensing deals?
- What is the typical structure of a pharma M&A deal?
- How do earnout provisions work in pharma licensing deals?
- What triggers antitrust review in pharma M&A?
- How are pharma deal valuations typically calculated?
- What is the significance of contingent value rights in acquisitions?
- Why is Eli Lilly spending $3.8 billion on vaccine developers?
- what is a licensing deal in pharma
Distribution
Economics
- What does gross-to-net mean in pharma?
- What is the gross-to-net bubble and why does it matter?
- How do pharma companies report rebate accruals in earnings?
- What drives specialty drug pricing in the US?
- How does the 340B program affect manufacturer economics?
- What are channel economics in pharmaceutical distribution?
PBM Negotiations
People
Pipeline
- What is the typical FDA approval timeline for a new drug?
- How does biosimilar interchangeability differ from FDA approval?
- What are the key late-stage pipeline catalysts to watch?
- What is the current probability of success from Phase 1 to approval?
- How do accelerated approval pathways affect pipeline strategy?
Policy & Regulation
- What is the IRA drug price negotiation program?
- What drugs are included in IRA Medicare price negotiation?
- How does the IRA inflation rebate penalty work?
- What is the current status of state PBM reform legislation?
- How does the FTC PBM investigation affect the industry?
- What is the Medicare Part D redesign under the IRA?
- What is Eli Lilly alleging in its $200M Trulicity rebate fraud lawsuit?
- what is trump's pharma deal
- what is a 340b contract pharmacy
- what is true about a 340b contract pharmacy
- what is a 340b pharmacy
Pricing
Theweek
- How is the Weekly Pharma Roundup different from daily news coverage?
- What criteria determine which stories make the weekly roundup?
- Why did the FDA delay its decision on AstraZeneca’s camizestrant?
- Why did the FDA delay its decision on AstraZeneca’s oral SERD camizestrant?
- How is Astellas addressing Xtandi patent loss while Moderna’s flu shot nears FDA review?
- What major FDA approvals and leadership changes occurred in pharma this week?
- Why do U.S. drug prices rise after launch while foreign prices fall?
- Why is Revolution Medicines shipping daraxonrasib before FDA approval?
- Why did Abivax shares drop after strong obefazimod phase 3 results?
- Why did the FDA reject Cingulate’s CTx-1301 ADHD drug application?
- Why is Revolution Medicines’ pancreatic cancer drug generating early expansion buzz?
- How will removing NIH job protections affect federal research oversight?
- How will Medicare Advantage premiums and out-of-pocket limits change by 2026?
- Why is Medicare Advantage growth slowing but deepening in 2026?
- Why did ResMed acquire Noctrix Health and its Nidra device for $340M?
- How is EY forecasting biotech growth and M&A trends through 2026?
- Why is the NIH considering a cap on the number of grants per investigator?
- How did J&J’s Imaavy perform in its warm autoimmune hemolytic anemia trial?
- Why did Prometheus raise $12B to develop artificial engineers?
- What does FDA approval of Sanofi’s Tzield mean for pediatric stage 3 diabetes?
- What early clinical results did Lilly report for its JAK2 Type II inhibitor AJ1-11095?
- How did Blood Cancer United secure a discontinued experimental cancer drug for patients?
- Which biotechs are analysts predicting as the next obesity buyout targets?
- How is the Trump administration tightening Medicare drug price negotiation rules?
- How are Medicare Advantage rebate flows affecting stand-alone Part D plans?
- How did Medicare Part D enrollment and premiums change in 2026?
- Which EU countries are calling for a unified pharmaceutical pricing framework?
- What are Kardigan’s plans for its $320 million IPO funding?
- How are peptide-based obesity drugs reshaping the metabolic drug pipeline?
- Which pharmaceutical companies are sponsoring the new 'Let’s Talk Alzheimer’s' podcast?
- What does the FDA approval of Merck’s Welireg-Keytruda combo mean for early kidney cancer?
- What does the FDA’s approval of Colorado’s Canadian drug import plan mean?
- Will Medicare start covering weight loss drugs under a temporary program?
- How is the FDA's stance influencing Moderna's mRNA flu vaccine prospects?
- Why is Verastem shifting focus after its pancreatic cancer trial results?
- Why did PwC say biopharma M&A reached full health in 2026?
- Why did Eli Lilly acquire 4E Therapeutics for non-opioid pain research?
- Why is Eli Lilly acquiring 4E Therapeutics for non‑opioid pain research?
- How are pharma companies improving deal readiness amid the 2026 M&A rebound?
- How does CMS's recalculation of Medicare Advantage star ratings affect bonuses?
- Why did Eli Lilly halt 340B drug discounts for certain hospitals?
- What is the significance of CARsgen’s Claudin18.2 CAR-T approval in China?
- What is Serapha Bio’s $230M launch and YolTech base-editing deal for AATD?
- How does Gilead’s Trodelvy first-line TNBC approval affect TROP2 ADC competition?
- What does the FDA label expansion for Ionis Tryngolza mean for severe hypertriglyceridemia?
- How did Otsuka’s centanafadine perform in its Phase 3b ADHD trial?
- What early results did Epicrispr report for its EPI-321 gene silencer in FSHD?
- Why are Medicare Trustees projecting faster growth in Part D spending?
- Why has the EU opened antitrust proceedings against Sanofi over Efluelda marketing?
- What new features are included in the FDA's expanded FDALabel database?
- What new FDA approvals did Trodelvy receive for first-line TNBC treatment?
- How is Eli Lilly using telehealth for its European Foundayo obesity drug launch?
- How are new embryo genome editing advances reigniting ethical debates in biopharma?
- What changes are lawmakers proposing in the new 340B overhaul bill?
- What is included in the FDA’s June 2026 list of off-patent drugs without generics?
- What does the FDA approval of Orca Bio’s Tregzi mean for matched donor stem cell transplants?
- What is the FDA-approved Tregzi therapy for preventing GVHD in blood cancer transplants?
- When did the FDA approve the first generic single-dose flu treatment?
- What is Orca Bio's FDA approved Tregzi cell therapy for blood cancer?
- What does the FDA approval of Casgevy for children under 12 mean?
- What did the FDA approve Amphastar’s Rextovy nasal spray for in 2026?
- What does the FDA's expanded approval of Tzield mean for newly diagnosed pediatric type 1 diabetes?
- Why is Medicare proposing new cuts to 340B drug payments in 2024?
- Why is the FDA warning about Apoquel Chewable overdoses in pets?
- How is the FDA increasing transparency around Competitive Generic Therapy approvals?
- How does Viridian’s Lumvoa compare to Amgen’s Tepezza for thyroid eye disease?
- What is the significance of China approving the first solid tumor CAR-T therapy?
- What is United Therapeutics' FDA-approved LungFX system for donor lungs?
- How are AI caution and 340B payment cuts reshaping biotech this week?
- What did the FDA approval of Trutakna mean for IgA nephropathy treatment?
- What does FDA approval of Vera’s Trutakna mean for the IgAN market?
- What age group can now receive Vertex’s Casgevy gene therapy?
- What does the FDA approval of Vera’s Trutakna mean for IgA nephropathy treatment?
- How does Dexcom’s Stelo OTC CGM raise pediatric health concerns?
- What will the FDA discuss at the August 2026 drug repurposing meeting?
- What does the FDA's 2026 Keytruda and Padcev approval mean for MIBC patients?
- What does FDA approval of subcutaneous Sarclisa Escena mean for multiple myeloma?
- Why did the FDA report zero PDUFA VII hires for FY2026?
- How does the FDA’s expanded Padcev-Keytruda approval affect AstraZeneca’s bladder cancer strategy?
- What is Apnimed planning with its IPO and FDA sleep apnea pill?
- What does the FDA's new at-home starting dose approval for Leqembi mean?
- What new FDA approval is GSK seeking for Jemperli in rectal cancer?